Lipidomics-Based Identification of Plasma Lipid Biomarkers in Tuberculosis-Coronary Artery Disease Comorbidity

Wenjing Zhao1, Pan Yan2, Yi Pei3,4

  • 1The Affiliated Changsha Central Hospital, Department of Cardiology, Hengyang Medical School, University of South China, Changsha, Hunan, People's Republic of China.

PubMed

Insights

This study identifies three key lipids—CE(20:0), PC(14:0_20:4), and CE(18:0)—as potential biomarkers for the early diagnosis of tuberculosis-coronary artery disease comorbidity (TB-CAD). These findings aid in understanding TB-CAD pathogenesis.

Area of Science:

  • Biochemistry
  • Clinical Medicine
  • Metabolomics

Background:

  • Cardiovascular disease (CVD) is the primary cause of mortality in tuberculosis (TB) patients.
  • Lipid metabolism disorders are common in patients with TB or coronary artery disease (CAD).
  • Early diagnosis of tuberculosis-coronary artery disease comorbidity (TB-CAD) is crucial.

Purpose of the Study:

  • To identify specific lipid biomarkers for the early diagnosis of TB-CAD.
  • To investigate differential lipid profiles in patients with TB, CAD, and TB-CAD.
  • To explore metabolic pathways associated with TB-CAD.

Main Methods:

  • Collected blood samples from TB, TB-CAD, CAD patients, and healthy controls (NC).
  • Utilized broad-targeted lipidomics via ultra-high-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS).
  • Applied K-Means analysis, receiver operating characteristic (ROC) curve analysis, and KEGG pathway analysis.

Main Results:

  • Decreased levels of sphingolipids, glycerolipids, and glycerophospholipids observed in TB-CAD patients.
  • Identified 49 differential lipids distinguishing TB-CAD from other groups.
  • Three lipids (CE(20:0), PC(14:0_20:4), CE(18:0)) showed potential as biomarkers with an integrated model achieving an AUC of 0.834.

Conclusions:

  • Identified novel lipid biomarkers for early TB-CAD diagnosis.
  • Established a foundation for further research into TB-CAD pathogenesis.
  • Highlighted the role of linoleic acid, alpha-linolenic acid, and arachidonic acid metabolism in TB-CAD.
Abstract